Which Factors Will Push The Parathyroid Disease Treatment Market To Achieve $3.1 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
#What Is The Projected Valuation Of The Parathyroid Disease Treatment Market In The Coming Years?#_x000D_
The market size for treatment of parathyroid diseases has seen considerable growth in the previous years. The expected rise is from $2.21 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. This growth during the historic period is due to factors like the increasing occurrence of chronic kidney disease, a rise in osteoporosis cases, heightened awareness of endocrine disorders, expansion in diagnostic facilities, and improved access to specialist healthcare services._x000D_
_x000D_
The market for parathyroid disease treatment is projected to experience significant expansion in the coming years, reaching a valuation of $3.10 billion by 2029 and exhibiting a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is influenced by factors such as an increasing aged population, non-surgical treatment prevalence, the rise in postmenopausal bone disorders, government-led initiatives for the management of rare diseases, and an amplified acceptance of minimally invasive parathyroidectomy. The forecast period is also expected to see trend shifts towards personalized hormone treatments, the creation of long-duration hormone analogs, the application of AI in endocrine diagnosis, emphasis on calcium-sensing receptor-focused drugs, and progress in parathyroid hormone analog technology._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=25866&type=smp_x000D_
_x000D_
#Which Growth Drivers Are Shaping The Parathyroid Disease Treatment Market Outlook?#_x000D_
The escalating occurrence of chronic kidney disease (CKD) is anticipated to boost the parathyroid disease treatment market’s expansion. This long-lasting ailment, characterized by a progressive deterioration of kidney function, often results in imbalances of minerals like calcium and phosphorus. The surging ubiquity of chronic kidney disease (CKD) is majorly attributed to the growing rate of diabetes, as consistently elevated blood sugar levels can progressively harm the kidney’s filtration system, causing diabetic nephropathy. The treatment of parathyroid disease plays a crucial role in managing chronic kidney disease (CKD), by addressing secondary hyperparathyroidism, a common issue in severe CKD that interferes with the equilibrium of calcium and phosphorus, leads to bone disease, and encourages vascular calcification. For instance, the Australian Institute of Health and Welfare, a government agency in Australia, reported in June 2024 that the mortality rates due to chronic kidney disease (CKD) had increased by 4.2% in 2021 and 6.2% in 2022. Furthermore, in 2022, CKD accounted for approximately 22,000 deaths, which was 11% of the total deaths in Australia, presenting a mortality rate of 84 out of every 100,000 people. Consequently, the escalating occurrence of chronic kidney disease is propelling the expansion of the parathyroid disease treatment market._x000D_
_x000D_
#What Is The Segment Breakdown Of The Parathyroid Disease Treatment Market?#_x000D_
The parathyroid disease treatment market covered in this report is segmented – _x000D_
_x000D_
1) By Treatment: Calcimimetics, Bisphosphonates, Plicamycin, Hormone Replacement Therapy, Other Treatments_x000D_
2) By Route Of Administration: Oral, Parenteral_x000D_
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy_x000D_
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Calcimimetics: Cinacalcet, Etelcalcetide_x000D_
2) By Bisphosphonates: Alendronate, Ibandronate, Risedronate, Zoledronic Acid_x000D_
3) By Plicamycin: Mithramycin (Plicamycin) Monotherapy, Combination Therapies Involving Plicamycin_x000D_
4) By Hormone Replacement Therapy: Estrogen Therapy, Progesterone Therapy, Combined Hormonal Therapies, Selective Estrogen Receptor Modulators (SERMs)_x000D_
5) By Other Treatments: Parathyroid Hormone (PTH) Analogues, Surgery (Parathyroidectomy), Dietary Supplements, Lifestyle And Nutritional Interventions_x000D_
_x000D_
#How Are Global Trends Impacting The Development Of The Parathyroid Disease Treatment Market?#_x000D_
Major corporations in the parathyroid disease treatment sector are concentrating their efforts on the production of groundbreaking products like parathyroid hormone prodrugs, designed to enhance calcium management and minimize the frequency of doses for hypoparathyroidism sufferers. Parathyroid hormone (PTH) prodrugs, which turn into active PTH within the body to control calcium and phosphate equilibrium, are essentially inactive substances. For example, Ascendis Pharma A/S, a biopharmaceutical firm based in Denmark, obtained approval from the US Food and Drug Administration (FDA) for YORVIPATH (palopegteriparatide), a prodrug of parathyroid hormone (PTH[1-34]), intended for the treatment of chronic hypoparathyroidism in adults, in August 2024. This daily treatment ensures persistent parathyroid hormone exposure over a 24-hour period, offering an alternative to traditional calcium and vitamin D supplementation by directly addressing the root hormone deficiency. The approval of YORVIPATH underlines the growing focus on advanced hormone replacement treatments aiming to improve adherence to treatment and yield superior clinical results for patients suffering from parathyroid conditions._x000D_
_x000D_
#Who Are The Major Stakeholders Operating In The Parathyroid Disease Treatment Market?#_x000D_
Major companies operating in the parathyroid disease treatment market are AstraZeneca PLC, Amgen Inc., Teijin Pharma Limited, Kyowa Kirin Co. Ltd., Shandong Buchang Pharmaceuticals Co. Ltd., OPKO Health Inc., Septerna Inc., Entera Bio Ltd., Visen Pharmaceuticals (Shanghai) Co. Ltd., Ascendis Pharma A/S, Aeterna Zentaris Inc., MBX Biosciences Inc., STERIS Healthcare Private Limited (subsidiary of STERIS plc), Crinetics Pharmaceuticals Inc., Amorphical Ltd., Vidasym Inc., Extend Biosciences Inc., Rani Therapeutics LLC, Pathalys Pharma Inc., ProLynx LLC. _x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
_x000D_
#Which Region Is Likely To Register The Fastest Growth In The Parathyroid Disease Treatment Market?#_x000D_
Asia-Pacific was the largest region in the parathyroid disease treatment market in 2024. The regions covered in the parathyroid disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=25866&type=smp_x000D_
_x000D_
Browse Through More Reports Similar to the Global Parathyroid Disease Treatment Market 2025, By The Business Research Company_x000D_
_x000D_
Hyperphosphatemia Treatment Global Market Report 2025_x000D_
_x000D_
Optic Nerve Disorders Treatment Global Market Report 2025_x000D_
_x000D_
Sarcopenia Treatment Global Market Report 2025_x000D_
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
